| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
X4 Pharmaceuticals, Inc (XFOR) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. XFOR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.33M | $9.60M | - | |
| Pres | 2.33M | $9.60M | - | |
| CFO | 1.55M | $6.40M | - | |
| Dir | 0 | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2022 | Dibiase Mary71 | Chief Operating Officer | Sell | 1,713 | $0.00 | - | -1.0% | +63.8% | +2.6% | |
| Aug 17, 2022 | Ragan Paula77 | President And CEO | Sell | 13,448 | $0.00 | - | -2.1% | +63.8% | +2.6% | |
| Aug 17, 2022 | Mostafa Adam S.75 | Chief Financial Officer | Sell | 10,834 | $0.00 | - | -5.9% | +63.8% | +2.6% | |
| Jun 30, 2022 | Mostafa Adam S.75 | Chief Financial Officer | Sell | 2,641 | $0.00 | - | -1.4% | +50.3% | +101.0% | |
| Jun 30, 2022 | Dibiase Mary71 | Chief Operating Officer | Sell | 1,578 | $0.00 | - | -0.9% | +50.3% | +101.0% | |
| Jun 24, 2022 | Mostafa Adam S.75 | Chief Financial Officer | Sell | 5,416 | $0.00 | - | -2.8% | -13.5% | +83.2% | |
| Jun 24, 2022 | Dibiase Mary71 | Chief Operating Officer | Sell | 856 | $0.00 | - | -0.5% | -13.5% | +83.2% | |
| Jun 24, 2022 | Ragan Paula77 | President And CEO | Sell | 6,724 | $0.00 | - | -1.0% | -13.5% | +83.2% | |
| Jun 24, 2022 | Meisner Derek M65 | Chief Legal Officer | Sell | 4,166 | $0.00 | - | -2.6% | -13.5% | +83.2% | |
| Jun 16, 2022 | Mostafa Adam S.75 | Chief Financial Officer | Sell | 5,416 | $0.00 | - | -2.7% | +4.7% | +101.9% |